Key result
Chilean pilot project outlines protocols for managing congenital Chagas disease via maternal screening and mandatory treatment.
A pilot study in Chile explored three protocols for the detection, treatment, and follow-up of congenital Trypanosoma cruzi infection in mothers and neonates.
Protocols must detect T. cruzi in pregnant women; pilot data leave optimal strategies open.
Given the increasing travel of pregnant women from areas were Trypanosoma cruzi is endemic, the congenital transmission of the parasite has become a global public-health problem. In a recent pilot study, which ran in Chile from 2006 to 2010, three strategies for exploring and managing T. cruzi-infected mothers and their infected or uninfected neonates were investigated. Any protocols applied to the investigation of such mother-and-child pairs need to include the detection of infection in pregnant women, the detection of infection, if any, in the children born to the women, the appropriate treatment of the infected neonates, and the serological-parasitological follow-up of all of the neonates until their medical discharge.
No takes yet. Share an insight, caveat, or question.
Zulantay et al. (2011) studied Congenital Trypanosoma cruzi infection (Chagas disease). Three protocols for detection and management of congenital Chagas disease was evaluated. A pilot project in Chile outlined three protocols for managing congenital Chagas disease, emphasizing maternal serological screening, neonatal parasitological testing, and mandatory treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: